IBRX earnings

Catalyst

IBRX earnings

IBRX earnings — 2026-05-11

Reported the quarter ending 2026-03-31: revenue $44M, diluted EPS $-0.62, net income $-633M (SEC filing). Across the print the stock moved -4.6% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

10 events
DateTypeEvent
Apr 20 Discord$IBRX and $RXRX ? Jun 16 UpdateBiotech Candidates Apr 3 UpdateBiotech Candidates Mar 31 ScanMonster Scan Jun 25 ScanMonster Scan Mar 26 ScanMonster Scan Jun 26 ScanMonster Scan Mar 20 ScanMonster Scan Jul 7 ScanMonster Scan Mar 13 ScanMonster Scan

No direct external sources are attached to this read.